44911-0703 NDC - MITOCHONDRIA PRO (ARALIA QUINQUEFOLIA, ARNICA MONTANA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, ASCORBICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CALCAREA CARBONICA, CITRICUM ACIDUM, CUPRUM METALLICUM, CYSTEINUM, FERRUM METALLICUM, IODIUM, LEVOTHYROXINUM, MAGNESIUM GLUCONICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM ACETICUM, NADIDUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SELENIUM METALLICUM, SULPHUR, THIAMINUM HYDROCHLORICUM, UBIDECARENONUM, ZINCUM METALLICUM,)

Drug Information

  • Product NDC: 44911-0703
  • Proprietary Name: Mitochondria PRO
  • Non Proprietary Name: Aralia Quinquefolia, Arnica Montana, Adenosinum Triphosphoricum Dinatrum, Alpha-Ketoglutaricum Acidum, Ascorbicum Acidum, Alpha-Lipoicum Acidum, Calcarea Carbonica, Citricum Acidum, Cuprum Metallicum, Cysteinum, Ferrum Metallicum, Iodium, Levothyroxinum, Magnesium Gluconicum Dihydricum, Malicum Acidum, Manganum Aceticum, Nadidum, Natrum Pyruvicum, Nicotinamidum, Pyridoxinum Hydrochloricum, Riboflavinum, Selenium Metallicum, Sulphur, Thiaminum Hydrochloricum, Ubidecarenonum, Zincum Metallicum,
  • Active Ingredient(s): 16 [hp_X]/mL ACONITIC ACID, (Z)-; 12 [hp_X]/mL ADENOSINE TRIPHOSPHATE DISODIUM; 12 [hp_X]/mL ALPHA LIPOIC ACID; 6 [hp_X]/mL AMERICAN GINSENG; 12 [hp_X]/mL ANHYDROUS CITRIC ACID; 6 [hp_X]/mL ARNICA MONTANA WHOLE; 30 [hp_X]/mL ARSENIC TRIOXIDE; 12 [hp_X]/mL ASCORBIC ACID; 35 [hp_C]/mL BARIUM OXALOSUCCINATE; 30 [hp_X]/mL BRYONIA ALBA ROOT; 30 [hp_X]/mL CINCHONA OFFICINALIS BARK; 30 [hp_X]/mL CONIUM MACULATUM FLOWERING TOP; 12 [hp_X]/mL COPPER; 12 [hp_X]/mL CYSTEINE; 30 [hp_X]/mL GELSEMIUM SEMPERVIRENS ROOT; 12 [hp_X]/mL IODINE; 12 [hp_X]/mL IRON; 12 [hp_X]/mL LEVOTHYROXINE; 12 [hp_X]/mL MAGNESIUM GLUCONATE; 12 [hp_X]/mL MALIC ACID; 12 [hp_X]/mL MANGANESE ACETATE TETRAHYDRATE; 30 [hp_X]/mL MERCURIUS SOLUBILIS; 12 [hp_X]/mL NADIDE; 12 [hp_X]/mL NIACINAMIDE; 12 [hp_X]/mL OXOGLURIC ACID; 12 [hp_X]/mL OYSTER SHELL CALCIUM CARBONATE, CRUDE; 12 [hp_X]/mL PYRIDOXINE HYDROCHLORIDE; 12 [hp_X]/mL RIBOFLAVIN; 12 [hp_X]/mL SELENIUM; 30 [hp_X]/mL SILICON DIOXIDE; 12 [hp_X]/mL SODIUM PYRUVATE; 12 [hp_X]/mL SULFUR; 12 [hp_X]/mL THIAMINE HYDROCHLORIDE; 12 [hp_X]/mL UBIDECARENONE; 12 [hp_X]/mL ZINC
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Acidifying Activity [MoA]; Analogs/Derivatives [Chemical/Ingredient]; Anti-coagulant [EPC]; Ascorbic Acid [CS]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Calculi Dissolution Agent [EPC]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Coagulation Factor Activity [PE]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibit Ovum Fertilization [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Magnetic Resonance Contrast Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Paramagnetic Contrast Agent [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Thyroxine [CS]; Vitamin B 6 [Chemical/Ingredient]; Vitamin B6 Analog [EPC]; Vitamin C [EPC]; l-Thyroxine [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Energique, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:12/28/2023
End Marketing Date:5/8/2029

Package Information

No. Package Code Package Description Billing Unit
144911-0703-130 mL in 1 BOTTLE, DROPPER (44911-0703-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC44911-0703The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEMitochondria PROThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAralia Quinquefolia, Arnica Montana, Adenosinum Triphosphoricum Dinatrum, Alpha-Ketoglutaricum Acidum, Ascorbicum Acidum, Alpha-Lipoicum Acidum, Calcarea Carbonica, Citricum Acidum, Cuprum Metallicum, Cysteinum, Ferrum Metallicum, Iodium, Levothyroxinum, Magnesium Gluconicum Dihydricum, Malicum Acidum, Manganum Aceticum, Nadidum, Natrum Pyruvicum, Nicotinamidum, Pyridoxinum Hydrochloricum, Riboflavinum, Selenium Metallicum, Sulphur, Thiaminum Hydrochloricum, Ubidecarenonum, Zincum Metallicum,The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE12/28/2023This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE5/8/2029This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEEnergique, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACONITIC ACID, (Z)-; ADENOSINE TRIPHOSPHATE DISODIUM; ALPHA LIPOIC ACID; AMERICAN GINSENG; ANHYDROUS CITRIC ACID; ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; ASCORBIC ACID; BARIUM OXALOSUCCINATE; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; COPPER; CYSTEINE; GELSEMIUM SEMPERVIRENS ROOT; IODINE; IRON; LEVOTHYROXINE; MAGNESIUM GLUCONATE; MALIC ACID; MANGANESE ACETATE TETRAHYDRATE; MERCURIUS SOLUBILIS; NADIDE; NIACINAMIDE; OXOGLURIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; SILICON DIOXIDE; SODIUM PYRUVATE; SULFUR; THIAMINE HYDROCHLORIDE; UBIDECARENONE; ZINCAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH16; 12; 12; 6; 12; 6; 30; 12; 35; 30; 30; 30; 12; 12; 30; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAcidifying Activity [MoA], Analogs/Derivatives [Chemical/Ingredient], Anti-coagulant [EPC], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Thyroxine [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC], l-Thyroxine [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/19/2025

Previous Code
Next Code